Bulgaria - Sofia: Various medicinal products

ID

ocds-pyfy63:2020-577082:2021-137097

Buyer

Ministerstvo na zdraveopazvaneto

Date

2021-03-19

Language

BG

Tags

award

Release in JSON

ID (OCID)

ocds-pyfy63:2020-577082

Releases

2020-12-01 (ocds-pyfy63:2020-577082:2020-577082)
2021-03-19 (ocds-pyfy63:2020-577082:2021-137097)
2021-04-23 (ocds-pyfy63:2020-577082:2021-201483)
2021-05-03 (ocds-pyfy63:2020-577082:2021-219650)

Releases in JSON

Title

Bulgaria - Sofia: Various medicinal products

Award criteria

priceOnly

Award criteria details

Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Main procurement category

goods

Procurement method

open

Procurement method details

Open procedure

Tender period

2021-03-19 - ?

ID

ocds-pyfy63:2020-577082:obj:1

Classification

CPV / 33690000

Description

Lamivudine/Zidovudine, форма — перорална форма, количество — до 7 200 tabl.

ID

ocds-pyfy63:2020-577082:obj:2

Classification

CPV / 33690000

Description

Lamivudine, перорална форма, количества — до 2 268 000 mg

ID

ocds-pyfy63:2020-577082:obj:3

Classification

CPV / 33690000

Description

Etravirine, перорална форма, количество — до 2 448 000 mg

ID

ocds-pyfy63:2020-577082:obj:4

Classification

CPV / 33690000

Description

Lopinavir/Ritonavir 200 mg/50 mg, перорална форма, количество — до 106 560 tabl.

ID

ocds-pyfy63:2020-577082:obj:5

Classification

CPV / 33690000

Description

Abacavir/Lamivudinе, перорална форма, количество — до 124 920 tabl.

ID

ocds-pyfy63:2020-577082:obj:6

Classification

CPV / 33690000

Description

Maraviroc, перорална форма, количество — до 216 000 mg

ID

ocds-pyfy63:2020-577082:obj:7

Classification

CPV / 33690000

Description

Ritonavir, перорална форма, количество — до 5 976 000 mg

ID

ocds-pyfy63:2020-577082:obj:8

Classification

CPV / 33690000

Description

Darunavir, перорална форма, количество — до 25 488 000 mg

ID

ocds-pyfy63:2020-577082:obj:9

Classification

CPV / 33690000

Description

Raltegravir, перорална форма, количество — до 120 960 000 mg

ID

ocds-pyfy63:2020-577082:obj:10

Classification

CPV / 33690000

Description

Zidovudine, перорална форма, количество — до 3 100 000 mg

ID

ocds-pyfy63:2020-577082:obj:11

Classification

CPV / 33690000

Description

Atazanavir, перорална форма, количество — до 6 156 000 mg

ID

ocds-pyfy63:2020-577082:obj:12

Classification

CPV / 33690000

Description

Efavirenz, перорална форма, количество — до 4 968 000 mg

ID

ocds-pyfy63:2020-577082:obj:13

Classification

CPV / 33690000

Description

Tenofovir disoproxil, перорална форма, количество — до 1 852 200 mg

ID

ocds-pyfy63:2020-577082:obj:14

Classification

CPV / 33690000

Description

Zidovudine, перорална форма, количество — до 103 600 ml

ID

ocds-pyfy63:2020-577082:obj:15

Classification

CPV / 33690000

Description

Lamivudine, перорална форма, количество — до 54 720 ml

ID

ocds-pyfy63:2020-577082:obj:16

Classification

CPV / 33690000

Description

Rilpivirine, перорална форма, количество — до 684 000 mg

ID

ocds-pyfy63:2020-577082:obj:17

Classification

CPV / 33690000

Description

Dolutegravir, перорална форма, количество — до 4 375 800 mg

ID

ocds-pyfy63:2020-577082:obj:18

Classification

CPV / 33690000

Description

Emtricitabine/Tenofovir disoproxil, перорална форма, количество — до 291 600 tabl.

ID

ocds-pyfy63:2020-577082:obj:19

Classification

CPV / 33690000

Description

Dolutegravir/Abacavir/Lamivudine, перорална форма, количество — до 162 360 tabl.

ID

ocds-pyfy63:2020-577082:obj:20

Classification

CPV / 33690000

Description

Darunavir/Cobicistat 800/150 mg, перорална форма, количество — до 90 000 tabl.

ID

ocds-pyfy63:2020-577082:obj:21

Classification

CPV / 33690000

Description

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide, перорална форма, количество — до 92 880 tabl.

ID

ocds-pyfy63:2020-577082:obj:22

Classification

CPV / 33690000

Description

Dolutegravir/Rilpivirine, перорална форма, количество — до 37 080 tabl.

ID

ocds-pyfy63:2020-577082:obj:23

Classification

CPV / 33690000

Description

Doravirine/Lamivudine/Tenofovir disoproxil, перорална форма, количество — до 42 840 tabl.

ID

ocds-pyfy63:2020-577082:obj:24

Classification

CPV / 33690000

Description

Doravirine, перорална форма, количество — до 1 800 000 mg

ID

ocds-pyfy63:2020-577082:obj:25

Classification

CPV / 33690000

Description

Bictegravir/Emtricitabine/Tenofovir alafenamide, перорална форма, количество — до 51 480 tabl.

ID

ocds-pyfy63:2020-577082:obj:26

Classification

CPV / 33690000

Description

Dolutegravir/Lamivudine, перорална форма, количество — до 47 880 tabl.

ID

ocds-pyfy63:2020-577082:obj:27

Classification

CPV / 33690000

Description

Methadone, перорална форма, количество — до 117 778 000 mg

ID

ocds-pyfy63:2020-577082:obj:28

Classification

CPV / 33690000

Description

Isoniazid, перорална форма, количество — до 94 500 000 mg

ID

ocds-pyfy63:2020-577082:obj:29

Classification

CPV / 33690000

Description

Rifampicin, перорална форма, количество — до 186 270 000 mg

ID

ocds-pyfy63:2020-577082:obj:30

Classification

CPV / 33690000

Description

Pyrazinamide, перорална форма, количество — до 247 400 000 mg

ID

ocds-pyfy63:2020-577082:obj:31

Classification

CPV / 33690000

Description

Ethambutol, перорална форма, количество — до 184 225 000 mg

ID

ocds-pyfy63:2020-577082:obj:32

Classification

CPV / 33690000

Description

Bedaquiline, перорална форма, количество — до 376 000 mg

ID

ocds-pyfy63:2020-577082:award:0

Status

unsuccessful

ID

ocds-pyfy63:2020-577082:award:1

Status

unsuccessful

ID

ocds-pyfy63:2020-577082:award:2

Status

unsuccessful

ID

ocds-pyfy63:2020-577082:award:3

Status

unsuccessful

ID

ocds-pyfy63:2020-577082:award:4

Status

unsuccessful

ID

ocds-pyfy63:2020-577082:award:5

Status

unsuccessful

ID

ocds-pyfy63:2020-577082:award:6

Status

unsuccessful

Roles

buyer

Organization name

Ministerstvo na zdraveopazvaneto

Street address

pl. „Sveta Nedelya“ No. 5

Locality

Sofiya

Postal code

1000

Country

BG

Contact name

Shenay Vehbieva Eminova

E-mail

seminova@mh.government.bg

Website

Link

Organization data Organization in JSON